Vera Bank, N.A. Gilead Sciences, Inc. Transaction History
Vera Bank, N.A.
- $445 Million
- Q2 2025
A detailed history of Vera Bank, N.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Vera Bank, N.A. holds 3,583 shares of GILD stock, worth $427,846. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,583Holding current value
$427,846% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,297Shares Held
1BCall Options Held
9.56MPut Options Held
9.96M-
Black Rock Inc. New York, NY121MShares$14.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$14 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$7.11 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.52 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.39 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...